Deakin University
Browse

Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China

Version 2 2024-06-02, 23:01
Version 1 2023-07-18, 04:48
journal contribution
posted on 2024-06-02, 23:01 authored by Z Dai, IOL Wong, C Xie, W Xu, Y Xiang, L Peng, Eric LauEric Lau
Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China

History

Journal

Clinical Microbiology and Infection

Volume

28

Pagination

300-300

Location

Amsterdam, The Netherlands

Publisher DOI

ISSN

1198-743X

eISSN

1469-0691

Language

eng

Author URL

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

2

Publisher

Elsevier

Usage metrics

    Research Publications

    Categories

    Keywords

    Uncategorised value

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC